Organigram (TSE:OGI) Price Target Lowered to C$3.15 at Canaccord Genuity Group

Organigram (TSE:OGI) had its price target decreased by equities researchers at Canaccord Genuity Group from C$3.60 to C$3.15 in a report released on Monday,BayStreet.CA reports. The firm presently has a “speculative buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 37.55% from the stock’s previous close.

Organigram Trading Up 0.9 %

OGI traded up C$0.02 during trading on Monday, reaching C$2.29. 327,523 shares of the company’s stock were exchanged, compared to its average volume of 296,367. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. Organigram has a fifty-two week low of C$1.61 and a fifty-two week high of C$3.95. The firm has a market capitalization of C$248.63 million, a PE ratio of -0.91, a P/E/G ratio of 0.42 and a beta of 1.13. The company’s fifty day moving average price is C$2.29 and its 200-day moving average price is C$2.32.

Insider Buying and Selling

In related news, Senior Officer Paolo De Luca sold 12,014 shares of Organigram stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. 31.32% of the stock is currently owned by company insiders.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.